{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:59:24Z","timestamp":1744153164821},"reference-count":34,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002775","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:38:44Z","timestamp":1069385924000},"update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants"],"prefix":"10.1002","author":[{"given":"Prakeshkumar S","family":"Shah","sequence":"first","affiliation":[{"name":"University of Toronto Mount Sinai Hospital; Department of Paediatrics and Institute of Health Policy, Management and Evaluation; 600 University Avenue Toronto ON Canada M5G 1XB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Ohlsson","sequence":"additional","affiliation":[{"name":"University of Toronto; Departments of Paediatrics, Obstetrics and Gynaecology and Institute of Health Policy, Management and Evaluation; Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,7,23]]},"reference":[{"key":"10.1002\/14651858.CD002775-BIB0001|cit1","first-page":"397A","article-title":"Alpha-1 proteinase inhibitor (A1PI) therapy for the prevention of chronic lung disease of prematurity (CLD) - a dose ranging study and meta analysis with previous randomized clinical trial (RCT)","volume":"47","author":"Dunn","year":"2000","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD002775-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"219A","DOI":"10.1203\/00006450-199804001-01299","article-title":"Neurodevelopmental outcome of babies <1250g enrolled in a randomised controlled trial (RCT) of alpha-1-proteinase inhibitor (a1PI) therapy","volume":"43","author":"Kelly","year":"1998","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD002775-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1542\/peds.101.1.89","article-title":"alpha 1- Proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized, controlled trial","volume":"101","author":"Stiskal","year":"1998","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD002775-BIB0004|cit4","first-page":"166","article-title":"Inactivation of alpha1 proteinase inhibitor in infants exposed to high concentrations of oxygen","volume":"123","author":"Bruce","year":"1981","journal-title":"American Review of Respiratory Disease"},{"issue":"1","key":"10.1002\/14651858.CD002775-BIB0005|cit5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000065.pub2","article-title":"Prophylactic corticosteroid for preterm delivery","author":"Crowley","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD002775-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000501.pub2","article-title":"Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants","author":"Darlow","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002775-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000047032","article-title":"Superoxide dismutase: a role in the prevention of chronic lung disease","volume":"74","author":"Davis","year":"1998","journal-title":"Biology of the Neonate"},{"key":"10.1002\/14651858.CD002775-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0022-3476(72)80197-5","article-title":"Serum trypsin inhibitory capacity and the idiopathic respiratory distress syndrome","volume":"81","author":"Evans","year":"1972","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002775-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1164\/ajrccm\/141.3.672","article-title":"A comparison of alpha 1-proteinase inhibitor methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone and specific beta-lactam inhibitors in an acute model of human polymorphonuclear leukocyte elastase-induced lung hemorrhage in the hamster","volume":"141","author":"Fletcher","year":"1990","journal-title":"American Review of Respiratory Disease"},{"key":"10.1002\/14651858.CD002775-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-9343(88)80069-X","article-title":"Preclinical evaluation of alpha-1-proteinase inhibitor. Pharmacokinetics and safety studies","volume":"84","author":"Fournel","year":"1988","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD002775-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1172\/JCI110344","article-title":"Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema","volume":"68","author":"Gadek","year":"1981","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD002775-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-3476(88)80390-1","article-title":"Effects of dexamethasone and indomethacin on elastase, alpha-1 proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates","volume":"113","author":"Gerdes","year":"1988","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002775-BIB0013|cit13","first-page":"691","article-title":"Drug facts and comparisons","volume-title":"Drug facts and comparisons","author":"Hebel","year":"2000"},{"key":"10.1002\/14651858.CD002775-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1542\/peds.92.2.191","article-title":"Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth","volume":"92","author":"Horbar","year":"1993","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD002775-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114305","article-title":"Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency","volume":"84","author":"Hubbard","year":"1989","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD002775-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM199303253281208","article-title":"Pulmonary surfactant therapy","volume":"328","author":"Jobe","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002775-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1203\/00006450-199606000-00007","article-title":"Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns","volume":"39","author":"Jones","year":"1996","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD002775-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1203\/00006450-199412000-00014","article-title":"Alpha1-antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity","volume":"36","author":"Koppel","year":"1994","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD002775-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(91)91167-S","article-title":"Aerosol alpha1- antitrypsin treatment for cystic fibrosis","volume":"337","author":"McElvaney","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002775-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1172\/JCI111015","article-title":"Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia","volume":"72","author":"Merritt","year":"1983","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD002775-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM196702162760701","article-title":"Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia","volume":"276","author":"Northway","year":"1967","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002775-BIB0022|cit22","first-page":"194","article-title":"Lung lavage of newborns with respiratory distress syndrome (RDS): prolonged neutrophil influx is associated with bronchopulmonary dysplasia (BPD)","volume":"125","author":"Ogden","year":"1982","journal-title":"American Review of Respiratory Disease"},{"key":"10.1002\/14651858.CD002775-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1651-2227.1964.tb07249.x","article-title":"Late stages of pulmonary hyaline membranes of the newborn","volume":"53","author":"Robertson","year":"1964","journal-title":"Acta Pediatrica Scandinavica"},{"key":"10.1002\/14651858.CD002775-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"403A","DOI":"10.1203\/00006450-198404001-01862","article-title":"Alpha1 antitrypsin (AAT) activity in development of bronchopulmonary dysplasia (BPD)","volume":"18","author":"Rosenfeld","year":"1984","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD002775-BIB0025|cit25","first-page":"1229","article-title":"Serial trypsin inhibitory capacity and ceruloplasmin levels in prematures at risk for bronchopulmonary dysplasia","volume":"134","author":"Rosenfeld","year":"1986","journal-title":"American Review of Respiratory Disease"},{"key":"10.1002\/14651858.CD002775-BIB0026|cit26","first-page":"50","article-title":"The changing incidence of chronic lung disease","volume":"25","author":"Shaw","year":"1993","journal-title":"Health Trends"},{"key":"10.1002\/14651858.CD002775-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.82.4.527","article-title":"Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period","volume":"82","author":"Shennan","year":"1988","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD002775-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0022-3476(64)80070-6","article-title":"The occurrence of pulmonary fibrosis in children who had idiopathic respiratory distress syndrome","volume":"65","author":"Shepard","year":"1964","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002775-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-3476(76)80736-6","article-title":"Alpha1-antitrypsin in amniotic fluid and cord blood of preterm infants with the respiratory distress syndrome","volume":"88","author":"Singer","year":"1976","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002775-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1183\/09031936.93.04020188","article-title":"Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight","volume":"4","author":"Watts","year":"1991","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002775-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM198704233161704","article-title":"Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema","volume":"316","author":"Wewers","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002775-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1044","article-title":"Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator- dependant infants with bronchopulmonary dysplasia","volume":"143","author":"Yoder","year":"1991","journal-title":"American Review of Respiratory Disease"},{"issue":"3","key":"10.1002\/14651858.CD002775-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002775","article-title":"Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants","author":"Shah","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD002775-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002775","article-title":"Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants","author":"Shah","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:02:26Z","timestamp":1682604146000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002775"}},"subtitle":[],"editor":[{"name":"Cochrane Neonatal Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2001,7,23]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002775","relation":{},"ISSN":["1465-1858"],"issn-type":[{"type":"electronic","value":"1465-1858"}],"subject":[],"published":{"date-parts":[[2001,7,23]]}}}